Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease
NCT03664674
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
148
Enrollment
INDUSTRY
Sponsor class
Conditions
Meniere Disease
Interventions
DRUG:
OTO-104
DRUG:
Placebo
Sponsor
Otonomy, Inc.